CTLA4 and neoplasm: T cells, which were thought to be primarily affected by ICB with anti-PD1 and anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) antibodies, can promote abnormal tumor vessel normalization (241–243).